Indolent B-Cell Lymphoma
Indolent B-Cell Lymphoma
The latest news, research, and perspectives in indolent B-cell lymphoma. This diverse group of slow-growing non-Hodgkin lymphomas form in B cells and include follicular lymphoma, hairy cell leukemia, and marginal zone lymphoma.
Advertisement
Nichole TuckerTransplantation & Cellular Therapy | May 22, 2025
The safety results from this phase 2 trial were also consistent with those observed in other studies.
Melissa BadamoAcute Lymphoblastic Leukemia | May 16, 2025
Studies have shown that oncologists are leaving the workforce at increasing rates in association with growing workloads.
Melissa BadamoIndolent B-Cell Lymphoma | May 9, 2025
Charles Gaulin, MBBS, discussed the future of lymphoma treatment, including the development of novel cellular therapies.
Melissa BadamoAcute Lymphoblastic Leukemia | May 8, 2025
LucyRx’s pharmacy network includes Northwestern Medicine Specialty Pharmacy, Dana Farber Cancer Institute, and more..
Melissa BadamoIndolent B-Cell Lymphoma | May 7, 2025
Charles Gaulin, MBBS, discussed the safety and efficacy of CD19 CAR-T cell therapy for transformed indolent lymphoma.
Andrew MorenoAggressive B-Cell Lymphoma | April 30, 2025
Efficacy and safety profile data were presented at the AACR Annual Meeting 2025.
Advertisement
Andrew MorenoTransplantation & Cellular Therapy | April 25, 2025
The ASCO Association Board Chair has written letters to the new heads of the CMS, FDA, and NIH.
Melissa BadamoAcute Lymphoblastic Leukemia | April 23, 2025
The Community Oncology Alliance outlined solutions for Congress to address systemic challenges of the U.S. healthcare system.
Melissa BadamoPrint | April 14, 2025
The award provides early-career researchers at NCCN Member Institutions with $150,000 in funding to support cancer research.
Nirav Shah, MD, MSHPTransplantation & Cellular Therapy | April 15, 2025
Nirav Shah, MD, MSHP, recently presented at the International Ultmann Chicago Lymphoma Symposium on this subject.
Melissa BadamoVideo Insights | April 15, 2025
Nicholas Freedman, DO, presented on symptom management and supportive care at the Tri-State Blood Cancer Conference.
Nichole TuckerAggressive B-Cell Lymphoma | April 9, 2025
United States District Judge Sean D. Jordan entered the final judgment to vacate a new FDA regulation regarding lab tests.
Melissa BadamoAcute Lymphoblastic Leukemia | April 8, 2025
More than 240 meetings were held with members of Congress as part of the ASCO 10th Annual Advocacy Summit.
Nichole TuckerAggressive B-Cell Lymphoma | April 1, 2025
Machine learning may aid point-of-care clinical decision-making for NHL patients receiving CAR T-cell therapy.
Melissa BadamoAcute Lymphoblastic Leukemia | March 14, 2025
Melody Smith, MD, MS, shares data on burnout in hematologist oncologists, why it occurs, and how to prevent it.
Andrew MorenoAggressive B-Cell Lymphoma | March 14, 2025
A panel moderated by Neil Love, MD, explored clinical data to assess these treatment approaches for the various types of NHL.
Andrew MorenoFollicular Lymphoma | March 14, 2025
This new approval adds upon the agent's indications for relapsed or refractory DLBCL and other large B-cell lymphomas.
Andrew MorenoAggressive B-Cell Lymphoma | March 14, 2025
Approved for adults ineligible for autologous transplant or CAR T-cell therapy following at least two systemic therapies.
Andrew MorenoAggressive B-Cell Lymphoma | January 29, 2025
The single-slide test helps clinicians differentiate more than 60 subtypes of these diseases from normal immune response.
Andrew MorenoTransplantation & Cellular Therapy | January 23, 2025
The therapies are under development for EBV-positive PTLD, non-Hodgkin lymphoma, and systemic lupus erythematosus.
Advertisement
Advertisement